A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Recruiting now

Conditions studied: Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, Menorrhagia

In brief

Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.

Key facts

Study ID

NCT05922657

Run by

Channel Medsystems

People needed

300

Starts

2023-06-09

Expected to finish

2027-12-31

Last updated by the study team

2026-06-22

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for a Cerene treatment
• 25 years of age and older
• Provided informed consent to participate in the registry
• English speaking
• Agrees to complete a survey at specified time points from baseline to 12 Months

You may not qualify if…

• Physician discretion
• Vulnerable populations

Where it is running

• Seven Hills Women's Health Centers — Cincinnati, Ohio, United States (enrolling)
• Axia Women's Health / Rubino OB/GYN Group — West Orange, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.